The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunological and genomic correlates of response to anti-PD1 checkpoint therapy in mismatch proficient and deficient patients with metastasized castration resistant prostate cancer.
 
Minke Smits
No Relationships to Disclose
 
Maarten Johannes van der Doelen
Research Funding - Bayer (Inst)
 
Harm Westdorp
No Relationships to Disclose
 
Inge M. van Oort
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst)
 
Michiel Sedelaar
Research Funding - Astellas Pharma (Inst); Sanofi (Inst)
 
Antoine Van Der Heijden
Research Funding - Ferring (Inst)
 
Alfred Witjes
Consulting or Advisory Role - BioCancell; Cepheid; MEL Pharma; Nucleix; Spectrum Pharmaceuticals; taris
Research Funding - cepheid (Inst); Nucleix (Inst); taris (Inst)
 
Jack A. Schalken
No Relationships to Disclose
 
Jolanda De Vries
No Relationships to Disclose
 
Winald R. Gerritsen
Consulting or Advisory Role - Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; CureVac; Janssen-Cilag; Merck Sharp & Dohme; Sanofi
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Celgene (Inst); EMD Serono (Inst); Pfizer (Inst)
 
Niven Mehra
Research Funding - Astellas Pharma (Inst); MSD (Inst)